FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/04/066249 [Registered on: 24/04/2024] Trial Registered Prospectively
Last Modified On: 11/04/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Dentistry 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   the effectiveness of bone graft alone versus when combined with adjuvant in management of bone cavity type irregularities in oral and maxillofacial region  
Scientific Title of Study   The effectiveness of demineralized freezed dried bone allograft alone versus when combined with platelet rich fibrin in the management of cystic defects in oral and maxillofacial region 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rudragouda R 
Designation  postgraduate 
Affiliation  A J institute of dental science 
Address  dr Rudragouda R postgraduate Dept. of Oral and Maxillofacial surgery A J Institute of dental sciences Kuntikana Mangalore
dr Rudragouda R postgraduate
Dakshina Kannada
KARNATAKA
575004
India 
Phone  9880244358  
Fax    
Email  rudragoudar05@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr U B Shabari 
Designation  Reader 
Affiliation  A J institute of dental science 
Address  dr. U B shabari Reader Dept. of Oral and Maxillofacial surgery A J Institute of dental sciences Kuntikana Mangalore Karnataka
dr. U B shabari Reader
Dakshina Kannada
KARNATAKA
575004
India 
Phone  9449753802  
Fax    
Email  ubbhaskar24@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr U B Shabari 
Designation  Reader 
Affiliation  A J institute of dental science 
Address  dr. U B shabari Reader Dept. of Oral and Maxillofacial surgery A J Institute of dental sciences Kuntikana Mangalore Karnataka
Dr. U B shabari Reader
Dakshina Kannada
KARNATAKA
575004
India 
Phone  9449753802  
Fax    
Email  ubbhaskar24@gmail.com  
 
Source of Monetary or Material Support  
A J institute of dental sciences mangaluru 
 
Primary Sponsor  
Name  Dr Rudragouda R 
Address  Dept. of Oral and Maxillofacial surgery A J Institute of dental sciences Kuntikana Mangalore 
Type of Sponsor  Other [individual] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rudragouda R  A J institute of dental sciences  Dept of Oral and Maxillofacial surgery A J Institute of dental sciences Kuntikana Mangalore
Dakshina Kannada
KARNATAKA 
9880244358

rudragoudar05@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
AJIDS Ethics committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: K099||Cyst of oral region, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  demineralized freezed dried bone allograt   demineralized freezed dried bone allograt alone is used as a graft material once at the procedure and then followed up to three months 
Intervention  demineralized freezed dried bone allograt combined with platelet rich fibrin  demineralized freezed dried bone allograt is combined with prf as a adjuvant is mixed together and used as a graft material once during the procedure and followed upto three months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1. Patients of either sex aged between 18 and 45 years.
2. Patients belonging to ASA 1 and 2.
3. Patients with cystic defect measuring above 5mms to 50 mms.
 
 
ExclusionCriteria 
Details  1. Pregnant or lactating women.
2. Patients diagnosed with systemic bone disorders
3. Patients under bisphosphonate therapy
4. Patients previously undergone radiotherapy
5. Patients contraindicated for graft placement.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   On-site computer system 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
bone density evaluation  baseline and 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Evaluate the efficacy of DFDBA in the management of Oral and Maxillofacial cystic defects  baseline 
Evaluate the efficacy of DFDBA combined with PRF in the management of Oral and Maxillofacial cystic defects  baseline 
Compare the effectiveness of DFDBA combined with PRF and DFDBA when used alone in Oral and Maxillofacial cystic defects to assess the bone volume restoration and overall defect resolution  baseline 
 
Target Sample Size   Total Sample Size="18"
Sample Size from India="18" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   this is a interventional prospective study including 18 patients which are devided into 2 groups of 9 patients each, group 1 will be DFDBA bone graft alone and group 2 will be DFDBA graft combined with PRF as an adjuvant.
this study aims to evaluate The effectiveness of demineralized freezed dried bone allograft alone versus when combined with platelet rich fibrin in the management of cystic defects in oral and maxillofacial region.

 
Close